Cardiovascular Diabetology

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

CARDIOVASC DIABETOL

ISSN / eISSN

1475-2840 / 1475-2840

Aims and Scope

Cardiovascular Diabetology is an open access, peer-reviewed, online journal that considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome; this includes genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research.

Cardiovascular Diabetology aims to provide an address for all types of scientific communications related to the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome. The impressive correlation between coronary artery disease and alterations in glucose metabolism has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents.

Subject Area

CARDIAC & CARDIOVASCULAR SYSTEMS

ENDOCRINOLOGY & METABOLISM

CiteScore

12.30

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Cardiology and Cardiovascular Medicine	Q1	#16/354
Medicine - Endocrinology, Diabetes and Metabolism	Q1	#17/232
Medicine - Internal Medicine	Q1	#14/140

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
CARDIAC & CARDIOVASCULAR SYSTEMS - SCIE	Q1
ENDOCRINOLOGY & METABOLISM - SCIE	Q1

H-index

Country/Area of Publication

ENGLAND

Publisher

BioMed Central

Publication Frequency

Irregular

Year Publication Started

2002

Annual Article Volume

284

Open Access

YES

Contact

BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL

Popular journals in the same field
Recent articles

Non-coding RNA-mediated endothelial-to-mesenchymal transition in human diabetic cardiomyopathy, potential regulation by DNA methylation: (2023) Eric Wang, Shali Chen, Honglin Wang, Tori Chen, Subrata Chakrabarti

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy: (2023) Katherine G. Young, Rhian Hopkins, Beverley M. Shields, Nicholas J. Thomas, Andrew P. McGovern, John M. Dennis,

Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells: (2023) Sheila González-Salvatierra, Cristina García-Fontana, Jesus Lacal, Francisco Andújar-Vera, Luis Martínez-Heredia, Raquel Sanabria-de la Torre, María F...

High BMI and the risk for incident type 1 Diabetes Mellitus: a systematic review and meta-analysis of aggregated cohort studies: (2023) Maya Nitecki, Hertzel C. Gerstein, Yulia Balmakov, Eyal Tsur, Vladislav Babushkin, Tomer Michaeli, Arnon Afek, Orit Pinhas-Hamiel, Tali Cukierman-Yaff...

Relationship between the circulating N-terminal pro B-type natriuretic peptide and the risk of carotid artery plaque in different glucose metabolic states in patients with coronary heart disease: a CSCD-TCM plus study in China: (2023) Tong Yang, Hongmei Zheng, Guangwei Pan, Ruiying Guo, Fengmin Liu, Shengyuan Liu, Shuang Tao, Lin Li, Rongrong Yang, Chunquan Yu

Sex-related differences for uric acid in the prediction of cardiovascular events in essential hypertension. A population prospective study: (2023) Maria Perticone, Raffaele Maio, Ermal Shehaj, Simona Gigliotti, Benedetto Caroleo, Edoardo Suraci, Angela Sciacqua, Francesco Andreozzi, Francesco Per...

Association between high sensitivity cardiac troponin and mortality risk in the non-diabetic population: findings from the National Health and Nutrition Examination Survey: (2023) Lin Liu, Yuen Ting Cheng, Aimin Xu, Bernard M. Y. Cheung

Assessment of left atrioventricular coupling and left atrial function impairment in diabetes with and without hypertension using CMR feature tracking: (2023) Rui Shi, Yi-Ning Jiang, Wen-Lei Qian, Ying-Kun Guo, Yue Gao, Li-Ting Shen, Li Jiang, Xue-Ming Li, Zhi-Gang Yang, Yuan Li

FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus: (2023) Wenfei Duan, Ruixiao Shi, Fang Yang, Zhoujunhao Zhou, Lihong Wang, Zhe Huang, Shufei Zang

The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease: (2023) Enmin Xie, Zixiang Ye, Yaxin Wu, Xuecheng Zhao, Yike Li, Nan Shen, Yanxiang Gao, Jingang Zheng

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

The magazine has high efficiency, with submissions being accepted within 20 days. The opinions of external reviewers are also very professional, and there is a relatively high requirement for statistical analysis.

2022-11-10

It's all good, except that the layout fee is too expensive. It's really frustrating without financial support and research incentives!

2023-04-09

View All Reviews

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now